EC grants EMA to DuoCort Plenadren Pharmaceutical Business Review DuoCort Pharma's Plenadren (hydrocortisone, modified release tablet) has received European Marketing Authorisation (EMA) by the European Commission (EC), to treat adrenal insufficiency in adults. Plenadren, an oral once daily tablet, is a dual release ... DuoCort Pharma's Orphan Drug PlenadrenĀ® Granted European Marketing ... EC Sanction of DuoCort's Plenadren Triggers ViroPharma's $33M Acquisition of ... DuoCort adrenal insufficiency drug OK'd in Europe |
